CORPORATE RENAISSANCE GROUP INC
10-Q, 1997-05-14
Previous: GREEN TREE FINANCIAL CORP, 424B2, 1997-05-14
Next: DEEPTECH INTERNATIONAL INC, 10-Q, 1997-05-14



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.

FORM 10-Q

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
     THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 1997
OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
     THE SECURITIES EXCHANGE ACT OF 1934


Commission File Number 0-20514

CORPORATE RENAISSANCE GROUP, INC.
(Exact Name of Registrant as Specified in its Charter)

Delaware                                               13-3701354
[State or other jurisdiction of                        (I.R.S. Employer
     incorporation or organization]                         Identification
Number)

1185 Avenue of the Americas
18th Floor
York, New York                                              10036
 (Address of principal executive offices)                   (Zip Code)

Registrant's telephone number, including area code:         (212) 730-2000


Former name, former address and fiscal year, if changed since last report

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days.  Yes  [X]     No  [ ]

The number of shares outstanding of the Registrant's common stock is 940,350 (as
of March 31, 1997).

<PAGE 1>


CORPORATE RENAISSANCE GROUP, INC.
INDEX

                                                                           Page
PART I - FINANCIAL INFORMATION

ITEM 1.

Statements of Assets and Liabilities
as of March 31, 1997 and September 30, 1996                                   3

Statements of Operations and Changes in
Net Assets for the Quarters ended March 31,
1997 and March 31, 1996 and for the Six
Months ended March 31, 1997 and March 31, 1996                                4

Statements of Cash Flows for the Six Months
ended March 31, 1997 and March 31, 1996                                       5

Schedule of Investments, March 31, 1997                                       6

Notes to Financial Statements                                              7-10


ITEM 2.

Management's Discussion and Analysis of
Financial Condition and Results of Operations                                11

PART II - OTHER INFORMATION
                                        

<PAGE 2>


                        CORPORATE RENAISSANCE GROUP, INC.
                      STATEMENTS OF ASSETS AND LIABILITIES
                                   (Unaudited)

<TABLE>
                                        
<CAPTION>
                                                    3/31/97         9/30/96

<S>                                               <C>            <C>
ASSETS
Investments in securities,
at market value (cost
$6,277,452 and $6,663,601
respectively)                                     $7,092,255     $9,217,962
Cash and cash equivalents                            258,130        509,257
Income taxes receivable                              344,152        345,511
Accrued interest receivable                              404            585
Other assets                                          27,497          6,247
                                                    ___________   _____________
Total Assets                                        7,722,438     10,079,562

LIABILITIES
Call options written, at
market value (premiums
received $41,827 at
September 30, 1996)                                        -         61,425
Accounts payable and
accrued expenses                                       3,555         31,659
Deferred taxes payable                                12,149        749,609
                                                    ___________   _____________
Total liabilities                                     15,704        842,693
                                                    ___________   _____________

Net assets                                          $7,706,734    $9,236,869
                                                    ___________   _____________
                                                    ___________   _____________


COMMITMENTS AND
CONTINGENCIES (NOTE 8)

NET ASSETS

Common stock (par value
$.01 per share 20,000,000
shares authorized; 956,100
shares issued and outstanding)                      $  9,561      $   9,561

Additional paid-in capital                          7,815,260     7,815,260
Treasury stock, at cost
(15,750 shares)                                     (125,137)             -
Accumulated income (losses):
Accumulated net operating loss
before security transactions                        (1,414,138)   (1,292,990)
Accumulated net realized gains
from sale of investments                             897,386      1,049,765
Net unrealized appreciation of
investments                                          523,802      1,655,273
                                                    ___________   _____________
                                                       7,050      1,412,048
                                                    ___________   _____________
Net assets                                          $7,706,734    $9,236,869
                                                    ___________   _____________
                                                    ___________   _____________


Net asset value per share
of common stock outstanding                         $   8.20      $    9.66
                                                    ___________   _____________
                                                    ___________   _____________

See notes to financial statements

</TABLE>
<PAGE 3>


                        CORPORATE RENAISSANCE GROUP, INC
               STATEMENTS OF OPERATIONS AND CHANGES IN NET ASSETS
                                   (Unaudited)

<TABLE>
<CAPTION>
                                       Quarter   Quarter   Six Months Six Months
                                         Ended     Ended      Ended      Ended
                                        3/31/97   3/31/96   3/31/97    3/31/96
                                        _______   _______   _______    ________
<S>                             <C>         <C>         <C>         <C>
Income:
Interest Income                         $2,957    $2,332    $ 8,151   $ 17,673
                                        ______    ______    _______   ________

Total investment income                  2,957     2,332      8,151     17,673
                                        ______     ______   ________   _______

Expenses:
Incentive fees                               -         -          -    224,128
Financial advisory fees                 50,000    50,000    100,000    100,000
Investment banking fees                      -    25,000      8,333     50,000
Professional fees                       12,300    15,300     24,600     27,600
Insurance expense                       11,750    18,500     25,750     37,247
Board of directors fees                 12,500    12,500     25,000     25,000
Other operating expenses                 5,674     9,787      9,204     12,736
                                        ______    ______    _______    _______
Total expenses                          92,224    131,087   192,887    476,711
                                        ______    _______   _______    _______

Operating loss before
income tax benefit                     (89,267) (128,755)  (184,736)  (459,038)

Income tax benefit                      29,885    45,454     63,588    175,177
                                        ______    ______     ______    _______

Net operating loss before
security transactions                  (59,382)  (83,301)  (121,148)  (283,861)
                                        ________  ________   ________ _________

NET REALIZED AND UNREALIZED
GAINS/(LOSSES) FROM INVESTMENTS:
Net realized gains/(losses)
from sales of investments          190,992     (59,541)   (237,762)   (125,992)
Change in net unrealized
(depreciation) of
investments                     (2,469,245) (3,683,282) (1,719,960) (1,799,862)
Income tax benefit arising
from net realized gains/
(losses) and net unrealized
(depreciation) of investments      787,028   1,321,318     673,872     601,428
                                   _______   _________     _______     _______

Net realized and unrealized
(losses) on investments        (1,491,225)  (2,421,505) (1,283,850) (1,324,426)
                                __________     __________     __________     __________
NET (DECREASE) IN
NET ASSETS RESULTING
FROM OPERATIONS           $(1,550,607)  $(2,504,806) $(1,404,998)  $(1,608,287)
                          ____________   ____________  ___________  __________
Net assets at beginning
of period                   9,257,341    12,709,121    9,236,869    11,812,602
Net decrease in net assets
resulting from treasury
stock purchases                    -             -      (125,137)            -
                          __________    __________     __________   __________

Net assets at 
end of period             $7,706,734    $10,204,315   $7,706,734   $10,204,315
                            __________   __________   __________    __________
                            __________   __________   __________    __________

Per Share Data:
Net operating loss before
security transactions                   $(.06)    $(.09)    $ (.13)   $  (.30)
Net realized gains/(losses)
from sales of investments                  .13     (.04)      (.16)      (.12)
Net unrealized
(depreciation) of investments           (1.71)    (2.49)     (1.20)     (1.27)
Net gain on treasury
stock transactions                           -         -        .03          -
                                      ________   ________  ________   ________
Net (decrease) in net asset
value resulting from operations         (1.64)    (2.62)     (1.46)     (1.69)
Net asset value per common
share at beginning of period              9.84     13.29       9.66      12.36
                                        _______   ______     ______      _____

Net asset value per common
share at end of period                  $8.20    $10.67      $8.20      $10.67
                                        ______    ______     ______     ______
                                        ______    ______     ______     ______

</TABLE>
<PAGE 4>


                        CORPORATE RENAISSANCE GROUP, INC.
                            STATEMENTS OF CASH FLOWS
                                   (Unaudited)
                                        
                                        


<TABLE>
<CAPTION>
                                        
                                                   SIX MONTHS    SIX MONTHS
                                                        ENDED         ENDED
                                                      3/31/97       3/31/96
                                                   ____________ ____________
<S>                                                    <C>           <C>

Cash Flows from Operating Activities:
Net (decrease) in net assets
resulting from operations                          $(1,404,998)  $(1,608,287)

Adjustments to reconcile
net increase in net assets
resulting from operations
to net cash (used in)
operating activiities:
Change in net unrealized
depreciation of investments                          1,719,960     1,799,862
Realized losses from
sale of investments                                    237,762       125,992
Deferred income tax (benefit)                         (737,460)     (587,314)

(Increase)/decrease in
operating assets:
Income taxes receivable                                  1,359      (179,884)
Accrued interest receivable                                181         2,900
Other assets                                           (21,250)      (36,842)

Increase/(decrease) in
operating liabilities:
Accrued incentive fee payable                                -      (996,947)
Income taxes payable                                         -      (132,008)
Due to broker                                                -       353,724
Accounts payable and
accrued expenses                                       (28,104)         (712)
                                                       _________    _________
Net cash flows (used in)
operating activities                                  (232,550)   (1,259,516)
                                                    _____________  __________

Cash Flows from
Investing Activities:
Purchase of securities                                (237,201)   (1,671,666)
Proceeds from sale of
securities                                             343,761       800,368
Proceeds from securities
sold short, not yet
purchased                                                    -        36,951
                                                      ___________   _________
Net cash flows provided
by (used in) investing
activities                                              106,560     (834,347)
                                                      ____________   __________

Cash Flows from Financing
Activities:
Purchase of treasury stock                             (125,137)             -
                                                      __________    __________
Net cash flows (used in)
financing activities                                   (125,137)             -
                                                     ___________   ___________
Net (decrease) in cash
and cash equivalents                                   (251,127)   (2,093,863)

Cash and Cash Equivalents,
at the beginning of the period                          509,257     2,093,863
                                                       __________    __________

Cash and Cash Equivalents,
at the end of the period                                258,130             0
                                                       __________   __________
                                                       __________   ___________

Supplemental Disclosure:
Income taxes paid/(refunded)                           $ (1,359)     $ 122,600
                                                       __________   __________
                                                       __________   __________



See notes to financial statements
</TABLE>

<PAGE 5>


                        CORPORATE RENAISSANCE GROUP, INC.
                          SCHEDULE OF INVESTMENTS  (1)
                                 MARCH 31, 1997
                                   (Unaudited)
                                        
<TABLE>
<CAPTION>

SHARES OR   TYPE OF ISSUE                                                 % OF
FACE        AND                                    ORIGINAL      MARKET    NET
VALUE       NAME OF ISSUER                             COST       VALUE ASSETS

        Reorganized Companies
        Common Stock
<C>     <S>                                       <C>         <C>         <C>

607,400 Computervision Corp. New                  $3,177,562  $3,264,775  42.4%
                                                  __________  __________
        Total Reorganized Companies               3,177,562    3,264,775
                                                  __________  __________

        Other Investments
        Common Stock

40,602  Tenet Healthcare Corp.  (2)                 423,199     999,824   13.0%
148,824 Seaman Furniture Co., Inc.                2,676,691   2,827,656   36.7%
                                                  __________ __________

        Total Other Investments                  3,099,980    3,827,480
                                                 __________   __________

                     Total Investments          $6,277,452   $7,092,255
                                                __________    __________
                                                __________    __________


Notes to Schedule of Investments

(FOOTNOTE   1)    The  above  investments  are  non-income  producing.    Equity
investments  that  have  not paid dividends within the last  twelve  months  are
considered to be non-income producing.  See Note 1.

(FOOTNOTE  2)   Effective  January 30, 1997, OrNda Healthcorp  merged  withTenet
Healthcare  Corp., in which the Company received 1.35 shares of Tenet  for  each
share of OrNda.

                        See notes to financial statements
</TABLE>

<PAGE 6>


                        CORPORATE RENAISSANCE GROUP, INC.
                          NOTES TO FINANCIAL STATEMENTS
                                        
                                 MARCH 31, 1997
                                   (Unaudited)
                                        
1.   Organization and Operation of the Company

      Corporate  Renaissance Group, Inc. (the "Company") was incorporated  under
the  laws  of  the State of Delaware on June 19, 1992.  The Company  is  a  non-
diversified, closed-end investment company which has elected to be treated as  a
business  development company ("BDC") under the Investment Company Act of  1940,
as  amended  by  the Small Business Incentive Act of 1980.  The  Company  offers
investors  the opportunity to participate in investments in companies which  the
Company believes have viable existing businesses generating substantial revenues
in  established  markets, and have recently completed or are in the  process  of
undergoing  financial restructuring ("Reorganized Companies") and  where,  as  a
result, the Company can ultimately obtain an equity position at a discount  from
market  value  for comparable companies that are not financially troubled.   The
Company's investments are generally not expected to produce meaningful levels of
investment   income.   It  is  the  Company's  objective  to  select  investment
opportunities  which  the Company believes offer the potential  for  substantial
capital appreciation.

      The Company completed its initial public offering and commenced operations
on  November 1, 1994.  The Company consummated the initial public offering  (the
"Domestic  Offering")  and  an overseas offering (the "Overseas  Placement")  of
956,000  shares at $10.00 per share.  Pursuant to the Domestic Offering, 600,000
shares  were sold; 356,000 shares were sold in the Overseas Placement (including
45,000  shares  sold  to Union d'Etudes et d'Investissments  ("UI")).   The  net
proceeds  to  the  Company of both the Domestic Offering and Overseas  Placement
were  $7,823,821 after deducting all costs associated with the registration  and
offering, resulting in an initial net asset value per share of $8.18.

      On  November  25,  1996, the Company's Board of Directors  authorized  the
implementation of an open market share repurchase program, pursuant to which the
Company, from time to time, may purchase up to an aggregate of 175,000 shares of
its common stock in open market transactions.  The purpose of the program is  to
provide  stockholders  desiring  to  sell  their  shares  with  enhanced  market
liquidity.  At the same time, the Company believes that open-market purchases of
its shares at a discount from net asset value will enhance long-term shareholder
value.     As  of  March  31, 1997, 15,750 shares have been  repurchased  at  an
average cost of $7.93 per share.

2.   Significant Accounting Policies

   a.          Valuation of Securities

      The  Company's  securities which are subject to  last-sale  reporting  are
valued by reference to the market price on a national securities exchange or  as
reported  on the National Association of Securities Dealers Automated  Quotation
System.  Other unlisted securities are valued at representative "bid" quotations
if  held long by the Company and representative "asked" quotations if held short
by  the  Company.  The value of securities for which market quotations  are  not
readily available and securities as to which the Company believes the method  of
valuation set forth above does not fairly reflect market value are determined by
one or more independent third parties selected by the Investment Adviser.


<PAGE 7>


   b.          Recognition of Security Transactions and Related Investment
   Income

      Security transactions are recorded on the date the order to buy or sell is
executed  (the  trade date).  Dividend income is recognized on  the  ex-dividend
date  and  interest income is recognized on an accrual basis.  The net  realized
gains  and losses in sales of securites are determined on a first in, first  out
or specific identification basis.

     c.   Accounting for Foreign Exchange Gains and Losses

      Investments  denominated in foreign currencies are  translated  into  U.S.
dollars at the closing foreign exchange rate.  Resulting foreign exchange  gains
and  losses  are  reflected  in  the change in net  unrealized  appreciation  of
investments.

     d.   Income Taxes

     The Company is not entitled to the special treatment available to regulated
investment companies and is taxed as a regular corporation for federal and state
income  tax  purposes.  The Company has accounted for income taxes in accordance
with  FASB Statement No. 109, "Accounting for Income Taxes."  The aggregate cost
of  securities  at March 31, 1997 for federal income tax purposes and  financial
reporting purposes was the same.

     e.   Cash and Cash Equivalents

      For the purpose of reporting cash flows, cash and cash equivalents consist
of cash and short-term interest-bearing deposits.

3.   Income Taxes

     The components of income tax (benefit) on pre-tax book loss of $2,142,458
are as follows:

     Federal:
     
                   Deferred                  $  (714,058)
                                             ___________
                                                (714,058)
                                             ___________
     
     State and Local:
     
                   Deferred                     (23,402)
                                             ___________
                                                (23,402)
                                             ___________
                                Total        $  (737,460)
                                             ___________
                                             ___________
     
      Deferred  income taxes arise from temporary differences  between  the  tax
basis  of  assets  and liabilities and their reported amounts in  the  financial
statements.   For  example, unrealized gains or losses on  investments  are  not
recognized  for  tax  purposes until realized and therefore create  a  temporary
difference.    The  Company's  deferred  income  tax  liability   is   primarily
attributable  to  the  net  unrealized appreciation  in  its  investments.   The
components of the Company's deferred income tax liability are comprised  of  the
following:

Deferred tax liability:
Net unrealized appreciation on investment      $271,565
Deferred tax asset:
Net operating loss carryforwards               (259,416)
                                               _________
     Net deferred tax liability                $ 12,149

     The Company's effective income tax rate and the U.S. federal statutory rate
are substantially the same.


<PAGE 8>


4.   Financial Advisory and Investment Banking Fees and
     Other Transactions with Affiliates and Related Parties

       The  Company  has  retained  M.D.  Sass  Investors  Services,  Inc.  (the
"Investment  Adviser")  as  the Company's investment  adviser.   The  Investment
Adviser is a registered investment adviser under the Investment Advisers Act  of
1940,  as  amended.   The Investment Adviser is part of a  group  of  affiliated
investment  advisers  and  other affiliated entities comprising  the  M.D.  Sass
organization  ("M.D. Sass").  Upon completion of the Company's offering  of  its
common shares, the Company entered into a Financial Advisory Agreement with  the
Investment Adviser, pursuant to which the Investment Adviser receives a base fee
of  $200,000 per annum, for furnishing the Company with administrative services,
including  necessary executive, administrative, internal accounting and  support
services.   In  addition  to the base fee, the Investment  Adviser  receives  an
incentive fee for its investment advisory services equal to 20% of the  increase
in net asset value of the Company's shares, as defined in the Financial Advisory
Agreement.  There were no incentive fees earned or payable at March 31, 1997.

      The Company was party to an investment banking agreement with UI USA, Inc.
for  a  period  of one year which ended on October 31, 1996.  Pursuant  to  this
agreement, UI USA furnished investment banking services to the Company for a fee
of  $100,000  per annum.  Such services consisted of assisting the  Company  and
Investment  Adviser in the evaluation, structuring and negotiation of investment
opportunities.   The Company paid $8,333 for such services covering  the  period
from October 1, 1996, through the date of termination of the agreement.

5.   Board of Directors Fees

      The  Company pays each of its five independent directors an annual fee  of
$10,000 for the directors' services as such.

6.   Investment Transactions

      As  of  March  31,  1997,  the  accumulated   unrealized  appreciation  of
investments was $814,803.

7.   Concentration of Credit Risk and Off-Balance Sheet Risk

      The  Company  engages  in  security purchase and  sale  transactions  with
regulated  broker-dealers.  In connection with these transactions,  the  Company
may  be  subject  to credit risk in the event the counterpart or  the  Company's
regulated clearing brokers cannot fulfill their contractual obligations.

     The Company's activities with off balance sheet risk include the writing of
traded  stock  market  index options.  The Company is  subject  to  market  risk
associated with changes in the value of the underlying stock index.  As a writer
of options, the Company receives a premium at the outset and then bears the risk
of unfavorable changes in the price of the stock index underlying the option.


<PAGE 9>


8.   Commitments and Contingencies

      In  March  1997, a non-binding letter of intent was entered  into  between
Computervision Corporation ("CVN") and the Investment Adviser pursuant to  which
the  Investment  Adviser and certain of its affiliates,  including  the  Company
(collectively,  the "Sass Group") would purchase a 51% interest  in  CVN's  Open
Service Solutions business unit ("OSS") in exchange for $30 million in cash  and
a  $25  million  Preferred Note.  The transaction is subject  to  financing  and
customary  closing  conditions.  In addition, the Sass  Group  will  be  granted
options  to purchase up to an additional 25% of CVN's remaining 49% interest  in
OSS.


<PAGE 10>


Item 2.        Management's Discussion and Analysis of Financial Condition
          and Results of Operations

      This  Report  contains,  in addition to historical  information,  forward-
looking  statements regarding Corporate Renaissance Group, Inc. (the "Company"),
which  represents  the  Company's expectations or  beliefs  including,  but  not
limited   to,  statements  concerning  the  Company's  operations,  performance,
financial  condition,  business  strategies and  other  information.   For  this
purpose,  any  statements contained in this Report that are  not  statements  of
historical  fact  may  be  deemed  to  be forward-looking  statements.   Without
limiting the generality of the foregoing, words such as "may," "will," "expect,"
"believe,"  "anticipate," "intend," "could," "estimate," or  "continue"  or  the
negative  or other variations thereof or comparable terminology are intended  to
identify  forward-looking statements.  The statements by  their  nature  involve
substantial  risk and uncertainties, certain of which are beyond  the  Company's
control,  and  actual results may differ materially depending on  a  variety  of
important  factors, including those described in this Report and  the  Company's
other filings with the Securities and Exchange Commission (the "Commission").

Liquidity and Capital Resources

      The Company is a non-diversified, closed-end management investment company
which has elected to be treated as a special type of investment company known as
a  business  development company under the Investment Company Act of  1940  (the
"1940 Act") as amended by the Small Business Act of 1980.  The Company's primary
investment  objective  is  to  achieve long-term  capital  appreciation  through
investments  in  companies ("Portfolio Investment") which the  Company  believes
have  viable  existing businesses generating substantial revenues in established
markets, but which have recently completed, are in the process of undergoing  or
are  likely  to  undergo  a financial restructuring pursuant  to  bankruptcy  or
reorganization  proceedings or on a negotiated basis outside  of  bankruptcy  or
reorganization proceedings (a "Reorganized Company") and where, as a result, the
Company  can  ultimately obtain an equity position (either common  or  preferred
stock)  at  a discount from market value for comparable companies that  are  not
financially  troubled.   Such  investments are not generally  available  to  the
public  because  they require large financial commitments and,  in  some  cases,
managerial assistance.  The Company may make these investments either on its own
or, more likely, jointly with other investors, including investment partnerships
managed  or  advised  by  M.D. Sass Investors Services,  Inc.  (the  "Investment
Adviser")  and its affiliates.  Any investments with affiliates of  the  company
will  be subject to restrictions under the 1940 Act and conditions set forth  in
an exemptive order granted by the Commission in November 1994.  A portion of the
Company's  portfolio  is invested in other securities, including  securities  of
financially  distressed  companies, where  the  Company  believes  that  it  can
generate capital appreciation by engaging portfolio trading.

     The Company has retained the Investment Adviser as the Company's investment
adviser  to  identify,  negotiate,  manage and  liquidate  investments  for  the
Company.  The Company invests only in transactions recommended by the Investment
Adviser.  The activities of the Investment Adviser on behalf of the Company  are
subject to supervision by the independent directors of the Company.

      The  Company's  primary source of working capital is funds generated  from
investment  activities.   At  March 31, 1997, the  Company  had  cash  and  cash
equivalents of $258,130, as compared to cash and cash equivalents of $509,257 at
September  30, 1996.  The decline in cash and cash equivalents was a  result  of
the  use  of  cash  equivalents to make additional investments and  pay  certain
operating expenses during the period.

      In  addition,  on  November  25, 1996, the Company's  Board  of  Directors
authorized  the  implementation  of  an open market  share  repurchase  program,
pursuant  to  which  the  Company, from time to time,  may  purchase  up  to  an
aggregate of 175,000 shares of its Common Stock in open market transactions.  As
of  March  31,  1997, the Company had purchased 15,750 shares pursuant  to  this
program at an average cost of $7.93 per share.


<PAGE 11>


Results of Operations

Quarter ended March 31, 1997 as compared to quarter ended March 31, 1996

     During the quarter ended March 31, 1997, the Company had interest income of
$2,957, as compared to interest income of $2,332 in the 1996 quarter.  Operating
expenses  during the 1997 quarter were $92,224, as compared to $131,087  in  the
1996  quarter.   This decrease is primarily attributable to fees payable  to  an
investment  banking  firm  accrued  during the  1996  quarter,  pursuant  to  an
Investment  Banking Agreement which expired in October 1996.   For  the  quarter
ended  March  31,  1997,  the Company had a pre-tax operating  loss  and  a  net
operating  loss of $89,267 and $59,382, respectively, as compared to  a  pre-tax
loss  and  net  operating  loss for the 1996 quarter of  $128,755  and  $83,301,
respectively.  Since the Company typically does not purchase securities with the
objective of generating investment income, net investment losses are expected to
routinely occur.

     During the quarter ended March 31, 1997, the Company had net realized gains
from  sale  of investments of $190,992, as opposed to net realized  losses  from
sale  of investments of $59,541 during the 1996 quarter.  For the quarter  ended
March  31,  1997, the Company had net unrealized depreciation of investments  of
$2,469,245,  as  compared  to  net  unrealized depreciation  of  investments  of
$3,683,282 in the 1996 quarter, both representing declines in  market  value  of
certain  portfolio  investments.  For the 1997  quarter,  the  Company  had  net
realized and unrealized losses on investments of $1,491,225, as compared to  net
realized and unrealized losses on investments of $2,421,505 for the 1996 quarter
and,  after  giving  effect to net operating losses, a decrease  in  net  assets
resulting  from operations of $1,550,607 in the 1997 quarter, as compared  to  a
decrease  in  net  assets resulting from operations of $2,504,806  in  the  1996
quarter.

Six months ended March 31, 1997 as compared to six months ended March 31, 1996

     During the six months ended March 31, 1997, the Company had interest income
of  $8,151,  as compared to interest income of $17,673 in the 1996 period.   The
decline  in  interest income reflects the increased percentage of the  Company's
assets  invested  in  other than cash or cash equivalents.   Operating  expenses
during  the  1997  period were $192,887, as compared to  $476,711  in  the  1996
period.   This decrease is primarily attributable to $224,128 in incentive  fees
payable to the Investment Adviser accrued during the 1996 period, as compared to
$0  in  the 1997 period and a decrease payable pursuant to an Investment Banking
Agreement from $50,000 in the 1996 period to $8,333 in the 1997 period.  For the
six months ended March 31, 1997, the Company had a pre-tax operating loss and  a
net operating loss of $184,736 and $121,148, respectively, as compared to a pre-
tax  loss  and net operating loss for the 1996 period of $459,038 and  $283,861,
respectively.  Since the Company typically does not purchase securities with the
objective of generating investment income, net investment losses are expected to
routinely occur.

      During  the six months ended March 31, 1997, the Company had net  realized
losses  from sale of investments of $237,762, as opposed to net realized  losses
from sale of investments of $125,992 during the 1996 period.  For the six months
ended March 31, 1997, the Company had net unrealized depreciation of investments
of  $1,719,960,  as  compared to net unrealized depreciation of  investments  of
$1,799,862  in  the  1996  period.  For the 1997 period,  the  Company  had  net
realized and unrealized losses on investments of $1,283,850, as compared to  net
realized and unrealized losses on investments of $1,324,426 for the 1996  period
and,  after  giving  effect to net operating losses, a decrease  in  net  assets
resulting  from operations of $1,404,998 in the 1997 period, as  compared  to  a
decrease  in  net  assets resulting from operations of $1,608,287  in  the  1996
period.


<PAGE 12>


Net Asset Value

      At March 31, 1997, the Company had a net asset value of $8.20 per share of
Common  Stock, a decrease of $1.46 per share from net asset value  at  September
30, 1996 of $9.66 per share.

PART II - OTHER INFORMATION


1.   Legal Proceedings

     Not applicable.


2.   Changes in Securities

     Not applicable.


3.   Default Upon Senior Securities

     Not applicable.


4.   Submission of Matters to a Vote of Security Holders

     (a)  On  February  19,  1997,  the  Company  held  its  Annual  Meeting  of
          Stockholders (the "Meeting").

     (b)  Not applicable.

     (c)  At the Meeting, the following matters were voted upon:

          (i)  Election of Directors.

     The following table sets forth the name of each nominee and the voting with
     respect to each nominee for director.

                                                    Withhold
     Name                          For              Authority

     Martin D. Sass             692,455             10,100
     Hugh R. Lamle              692,655              9,900
     James B. Rubin             659,655             22,900
     Thomas M. Garvin           659,655             22,900
     Lawrence W. Leighton       692,655              9,900
     Edward Lowenthal           692,655              9,900
     Daniel E. Mazziota         692,655              9,900
     Guy E. Waldvogel           659,655             22,900


<PAGE 13>


          (ii) Ratification  of  the appointment of Ernst &  Young  LLP  as  the
               Company's  independent public accountants  for  the  year  ending
               September 30, 1997.

               With  respect to the foregoing matter, 701,555  shares
               voted  in  favor,  1,000 shares against and 0  shares  abstained.
               There were no broker non-votes.


5.   Other Information

      In  March  1997, a non-binding letter of intent was entered  into  between
Computervision Corporation ("CVN") and the Investment Adviser pursuant to  which
the  Investment  Adviser and certain of its affiliates, including  the  Company,
would  purchase  a  51% interest in CVN's Open Service Solutions  business  unit
("OSS")  in  exchange for $30 million in cash and a $25 million Preferred  Note.
The  transaction is subject to financing and customary closing  conditions.   In
addition, the Investment Adviser will be granted options to purchase  up  to  an
additional 25% of CVN's remaining 49% interest in OSS.

      The  Investment  Adviser  and  certain of its  affiliates,  including  the
Company,  hold approximately 16% of CVN's outstanding capital stock.  In  April,
1997, James B. Rubin, the Company's Senior Vice President and an officer of  the
Investment Adviser, was elected to the Board of Directors of CVN.


6.   Exhibits and Reports on Form 8-K

     (a)  Exhibits - None.

     (b)  Reports on Form 8-K - None.


<PAGE 14>


                           SIGNATURES

      Pursuant  to the requirements of the Securities Exchange Act of 1934,  the
Registrant  has  duly  caused this report to be signed  on  its  behalf  by  the
undersigned thereunto duly authorized.

Date:  May 14, 1997       CORPORATE RENAISSANCE GROUP, INC.



                          By:/s/ Martin D. Sass
                          ______________________________________________
                             Martin D. Sass, Chairman of the Board and
                             Chief Executive Officer



                          By:/s/ Martin E. Winter
                          ______________________________________________
                             Martin E. Winter, Secretary-Treasurer
                             (Principal Financial and Accounting Officer)


<PAGE 15>


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                         258,130
<SECURITIES>                                 7,092,255
<RECEIVABLES>                                  372,053
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             7,722,438
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               7,722,438
<CURRENT-LIABILITIES>                           15,704
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         9,561
<OTHER-SE>                                   7,697,173
<TOTAL-LIABILITY-AND-EQUITY>                 7,722,438
<SALES>                                              0
<TOTAL-REVENUES>                           (1,949,571)
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               192,887
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,142,458)
<INCOME-TAX>                                 (737,460)
<INCOME-CONTINUING>                        (1,404,998)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,404,998)
<EPS-PRIMARY>                                   (1.46)
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission